Aims and scope Subscription Info for authors Editor-in-chief Editorial Board Contacts
International journal of Immunopathology, allergology, infectology.

Immunocorrecting effect of glucosamine-muramylpeptide in cases of bronchial asthma in children

Titova N.D., Novikova V.I.

1 Belarusian Medical Academy of Postgraduate Education
2 Vitebsk State Medical University

The application of glucosamine-muramylpeptide for allergic bronchial asthma treatment in children reduced the duration of asthma exacerbations caused by infection, increased sigA level, decreased total IgE, reduced the frequency of disimmunoglobulinaemia. decreased the IgE-level to fungal allergens, modified the cytokine profile from Th2 (IL-4, IL-5 j to Thl (IL-2. INFy).


Bronchial asthma, children, glucosamine-muramylpeptide.

Fulltext in PDF

Open file
Size: 1149 KB




Titova N.D., Novikova V.I. Immunopathology, allergology, infectology 2017; 1:31-36. DOI: 10.14427/jipai.2017.1.31